🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Apmonia Therapeutics announced in feb 2022 a 4 M€ fundraising round to complete regulatory preclinical studies of its anti-cancer immunotherapy drug candidate (AP-01) Portfolio of therapeutic #peptides targeting #tumor microenvironment in solid tumors apmonia-therapeutics.com/index.php/2022…

Apmonia Therapeutics awarded “Scale-Up of the Year” (North of France) during EY France Entrepreneur of the Year 30th ceremony This price rewards ground-breaking innovation and the considerable potential of ourtechnological platform for delivering new therapies #cancer #oncology

Bel article sur Apmonia Therapeutics et sa technologie dans Les Echos Merci EY France pour cette mise en lumière Nice article presenting Apmonia Therapeutics and the company's technology in Les Echos Many thanks EY France for this highlight lesechos.fr/thema/articles… #Cancer #oncology

Come and meet our CEO Albin JEANNE next week in Strasbourg at @BIOFIT_EVENT, the European marketplace for deals in life sciences.

Apmonia Therapeutics and partners Gustave Roussy and CNRS 🌍 will be presenting a poster at the 2023 ESMO - Eur. Oncology - European Society for Medical #Oncology #Gynecological #Cancers annual congress taking place 23-24 February in Barcelona, Spain.

📺Témoignage vidéo de la #startup Apmonia Therapeutics qui se développe à #Reims ! Le #GrandReims, #territoire d'#innovation et d'#entrepreunariat doté d'un #écosystème adapté et d'une localisation stratégique ! #ReimsVisionR #TousLégendR à voir sur Linkedin 👇 linkedin.com/company/reimsl…